Invivyd
Biotechnology Research
1601 Trapelo Rd
107 employees
IVVD
- Employees
- 107
- Contacts
- 3
- Emails
- 3
- Phones
- 1
Invivyd Overview
- Headquarters
- 1601 Trapelo Rd
- Website
- www.invivyd.com
- Industry
- Biotechnology Research
- Employees
- 107
- Founded
- 2020
- Stock Symbol
- IVVD
- Funding
- 30.0M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Invivyd
Invivyd, Inc. (Nasdaq: IVVD) creates medicines that are more potent and resistant to virus evolution than the human immune system. We deploy a proprietary integrated technology platform unique in the industry to assess, monitor, drug and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more. #covid19 #immunocompromised
Invivyd Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Invivyd Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Paul Grous | Head of IT, Invivyd | Sudbury, Massachusetts, United States |
Email
Phone
|
| Danielle Looney | Milton, Massachusetts, United States |
Email
|
|
| John Landry | Greater Hartford, United States |
View
|
|
| William Duke | Shrewsbury, Massachusetts, United States |
Email
|
Compare Similar Companies to Invivyd
Vertex Pharmaceuticals
Biotechnology Research
Alnylam Pharmaceuticals
Biotechnology Research
Argenx
Biotechnology Research
Madrigal Pharmaceuticals
Pharmaceutical Manufacturing
Beam Therapeutics
Biotechnology Research
Kymera Therapeutics
Biotechnology Research
Apogee Therapeutics
Biotechnology Research
Amylyx Pharmaceuticals
Pharmaceutical Manufacturing
X4 Pharmaceuticals
Biotechnology Research
Xilio Therapeutics, Inc.
Biotechnology Research